Skip to main content

Dirk van den Boom

CombiMatrix has appointed Dirk van den Boom to its board of directors. Dirk most recently served as president, CEO, and director of Sequenom, prior to its acquisition by LabCorp in September 2016. During his 18 year tenure at Sequenom, he held positions of increasing responsibility including chief scientific and strategy officer, executive VP of research and development, chief technology officer, and senior VP of research and development.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.